This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paraskevaidis, I. A. Articles by Kremastinos, D. T. Search for Related Content PubMed PubMed Citation Articles by Paraskevaidis, I. A. Articles by Kremastinos, D. T.

Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption

18-month follow-up study

^a Second Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece

View larger version (15K): [in a new window]   Figure 1 The left ventricular end-systolic diameter (LVESD) response to dobutamine in the terminal (group I, n = 9) and survival (group II, n = 18) groups.

View larger version (15K): [in a new window]   Figure 2 The end-systolic (meridional) wall stress (SWS) response to dobutamine in the terminal (group I, n = 9) and survival (group II, n = 18) groups.

View larger version (12K): [in a new window]   Figure 3 Dobutamine-induced changes in left ventricular end-systolic diameter (ESD).

View larger version (12K): [in a new window]   Figure 4 Dobutamine-induced changes in end-systolic (meridional) wall stress (SWS).